can semaglutide cause high blood sugar Is GLP-1 the Same as Ozempic? The Effects of Diabetes on
Description
The 2023 phase 2 double-blind, randomized controlled trial evaluating a GLP-1/GIP/glucagon receptor triagonist (retatrutide) in patients with the disease of obesity reported 24.2% weight loss at 48 weeks with 12 mg retatrutide
You can think of it like milk or fresh food
This dual benefit underscores its importance as a therapeutic option
[DOI] [PubMed] [Google Scholar] 130.Hu Y, Cardounel A, Gursoy E, Anderson P, Kalimi M
The microdose program uses sub-therapeutic doses primarily aimed at reducing food noise and cravings without the stronger appetite suppression of full doses
